Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
27,212,732
-
Share change
-
+869,231
-
Total reported value
-
$1,151,636,509
-
Put/Call ratio
-
45%
-
Price per share
-
$42.32
-
Number of holders
-
126
-
Value change
-
+$26,731,112
-
Number of buys
-
83
-
Number of sells
-
49
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2015
As of 30 Sep 2015,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,212,732 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, Redmile Group, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, ALLIANCEBERNSTEIN L.P., Visium Asset Management, LP, JPMORGAN CHASE & CO, GILDER GAGNON HOWE & CO LLC, and EAGLE ASSET MANAGEMENT INC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.